GROUP ONE TRADING, L.P. - IMMUNOPRECISE ANTIBODIES LTD ownership

IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 29 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of IMMUNOPRECISE ANTIBODIES LTD
ValueSharesWeighting
Q3 2023$4,359
-6.9%
2,382
+50.6%
0.00%
Q2 2023$4,683
+57.5%
1,582
+182.0%
0.00%
Q4 2022$2,973
-81.4%
561
-86.2%
0.00%
Q3 2022$16,000
+128.6%
4,061
+118.2%
0.00%
Q2 2022$7,000
-61.1%
1,861
-46.3%
0.00%
Q1 2022$18,000
-87.3%
3,466
-84.8%
0.00%
Q3 2021$142,00022,7780.00%
Other shareholders
IMMUNOPRECISE ANTIBODIES LTD shareholders Q3 2021
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 396,425$5,927,0000.29%
Gradient Capital Advisors, LLC 21,718$325,0000.18%
Hillsdale Investment Management Inc. 15,200$232,0000.02%
Orion Portfolio Solutions, LLC 15,821$237,0000.01%
IFP Advisors, Inc 1,960$30,0000.00%
BANK OF AMERICA CORP /DE/ 300$4,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
CITIGROUP INC 7$00.00%
MORGAN STANLEY 2,100$31,0000.00%
BANK OF MONTREAL /CAN/ 5,900$98,0000.00%
View complete list of IMMUNOPRECISE ANTIBODIES LTD shareholders